Evofem Biosciences, Inc. (EVFM)
0.0067
0.00 (0.00%)
USD |
OTCM |
Oct 23, 16:00
Evofem Biosciences EPS Diluted (Quarterly) : -0.0811 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0811 |
| March 31, 2026 | -0.0412 |
| December 31, 2025 | 0.022 |
| September 30, 2025 | -0.014 |
| June 30, 2025 | -0.0154 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | -0.0288 |
| September 30, 2024 | -0.0246 |
| June 30, 2024 | -0.0012 |
| March 31, 2024 | -0.1557 |
| December 31, 2023 | -0.7278 |
| September 30, 2023 | 0.0976 |
| June 30, 2023 | -5.430 |
| March 31, 2023 | -1.851 |
| December 31, 2022 | -11.66 |
| September 30, 2022 | -4.391 |
| June 30, 2022 | -571.65 |
| March 31, 2022 | -360.24 |
| December 31, 2021 | -611.72 |
| September 30, 2021 | -900.17 |
| June 30, 2021 | -500.72 |
| March 31, 2021 | -1057.29 |
| December 31, 2020 | -937.20 |
| September 30, 2020 | -690.36 |
| June 30, 2020 | -1711.52 |
| Date | Value |
|---|---|
| March 31, 2020 | -744.84 |
| December 31, 2019 | -502.58 |
| September 30, 2019 | -559.50 |
| June 30, 2019 | -1809.52 |
| March 31, 2019 | -1260.15 |
| December 31, 2018 | -1087.93 |
| September 30, 2018 | -1340.59 |
| June 30, 2018 | -2081.25 |
| March 31, 2018 | -8662.50 |
| December 31, 2017 | -118653.2 |
| September 30, 2017 | -430993.7 |
| June 30, 2017 | -42525.00 |
| March 31, 2017 | -35325.00 |
| December 31, 2016 | -1575.00 |
| September 30, 2016 | -1912.50 |
| June 30, 2016 | -2137.50 |
| March 31, 2016 | -4950.00 |
| December 31, 2015 | -7762.50 |
| September 30, 2015 | -14175.00 |
| June 30, 2015 | -7762.50 |
| March 31, 2015 | -5625.00 |
| December 31, 2014 | -5062.50 |
| September 30, 2014 | -3175.09 |
| December 31, 2013 | -2192.96 |
| September 30, 2013 | -1722.04 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 0.0858 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.04M |
| Revenue (Quarterly) | 2.633M |
| Total Expenses (Quarterly) | 13.67M |
| Enterprise Value | 59.95M |
| Gross Profit Margin (Quarterly) | 80.06% |
| Profit Margin (Quarterly) | -419.1% |
| Earnings Yield | -1.71K% |
| Normalized Earnings Yield | -1108.96 |